Atlas Trials

A Year Long Study to Evaluate the Safety of the Combination of Valsartan (320 mg) and Amlodipine (5 mg) in Patients With Hypertension

Clinical trial NCT00170976 · COMPLETED

Trial details

NCT number
NCT00170976
Sponsor
Novartis
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
HYPERTENSION
Start date
2004-04-01
Primary completion
2005-06-01
Enrollment
403

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.